More Cyclopharm Limited news
Cyclopharm LimitedASX: CYC

TECHNEGAS Awarded US Pass-Through Reimbursemt Status

Jun 5, 2024 at 12:52 AM EDT · Issued by Cyclopharm Limited

Filed with ASX · Jun 5, 2024 at 12:52 AM EDT

On 6ix: 6ix.com/news/technegas-awarded-us-pass-through-reimbursemt-status

Cyclopharm Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cyclopharm Limited on 6ix

Earlier from Cyclopharm

  • Cyclopharm Successfully Completes A$20.0 Million PlacementMay 27, 2024
  • Cyclopharm Capital RaisingMay 24, 2024
  • Cyclopharm Capital Raising PresentationMay 24, 2024
  • Cyclopharm Business UpdateMay 5, 2024
  • First USA Patients Imaged with TechnegasMar 18, 2024

Later from Cyclopharm

  • Cyclopharm Presenting at Macquarie Emerging Leaders ConfJun 18, 2024
  • USA Reimbursement Update for TECHNEGASJun 23, 2024
  • Cyclopharm completes oversubscribed Share Purchase PlanJun 24, 2024
  • Cyclopharm 2024 H1 Trading and USA Expansion UpdateAug 26, 2024
  • Cyclopharm - 2024 First Half Results & USA Expansion UpdateSep 2, 2024
All Cyclopharm news releases↗

Follow Cyclopharm into a list and get an email when it puts out news.

Follow Cyclopharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer